AMENDMENT NO. 5 TO AMENDED AND RESTATED CREDIT AGREEMENT

Contract Categories: Business Finance - Credit Agreements
EX-4.8(E) 6 dex48e.htm AMENDMENT NO. 5 TO LYONDELL CREDIT AGREEMENT DATED AS OF JUNE 25, 2004 Amendment No. 5 to Lyondell Credit Agreement dated as of June 25, 2004

Exhibit 4.8(e)

 

AMENDMENT NO. 5 TO AMENDED AND

RESTATED CREDIT AGREEMENT

 

AMENDMENT dated as of June 25, 2004 to the Amended and Restated Credit Agreement dated as of June 27, 2002 (as heretofore amended, the “Credit Agreement”) among LYONDELL CHEMICAL COMPANY, a Delaware corporation (the “Borrower”); the LENDERS from time to time party thereto; BANK OF AMERICA, N.A. and CITIBANK, N.A., as Co-Syndication Agents; SOCIETE GENERALE and UBS WARBURG LLC, as Co-Documentation Agents; and JPMORGAN CHASE BANK, as administrative agent (in such capacity, the “Administrative Agent”).

 

The parties hereto agree as follows:

 

SECTION 1. Defined Terms; References. Unless otherwise specifically defined herein, each term used herein which is defined in the Credit Agreement has the meaning assigned to such term in the Credit Agreement. Each reference to “hereof”, “hereunder”, “herein” and “hereby” and each other similar reference and each reference to “this Agreement” and each other similar reference contained in the Credit Agreement shall, after this Amendment becomes effective, refer to the Credit Agreement as amended hereby.

 

SECTION 2. Amended Definitions. (a) The following definitions in Section 1.01 of the Credit Agreement are amended to read in their entirety as follows:

 

Acquisition” means the acquisition by the Borrower, directly or indirectly, of ARCO Chemical and of Millennium.

 

Borrower Joint Ventures” means Equistar, LCR, Millenium and any Future Joint Venture, and “Borrower Joint Venture” means any of them, as the context may require.

 

Distributable Cash Flow” means with respect to any Borrower Joint Venture or non-wholly owned Subject Assets Transferee for any period, an amount equal to the lesser of “A” or “B” where:

 

A” equals the greater of (i) zero and (ii) the Borrower’s direct and/or indirect share of the cash from operations (as defined in accordance with GAAP and adjusted to exclude the effect of any extraordinary gain or loss) of such Person for such period minus the Borrower’s direct and/or indirect share of the gross capital expenditures of such Person for such period; and

 

B” equals the greater of (i) zero and (ii) cash distributions by such Person to the Borrower or a JV Subsidiary during such period (including repayment of Investments made in such Person by the Borrower or a Subsidiary) less the aggregate amount of Investments made by the Borrower or a Subsidiary in such


Person during such period (other than Investments permitted by clause (B) of Section 5.24 and clause (ii) of the proviso to Section 5.24). For purposes of calculations hereunder, Investments made within 45 days after the end of a Fiscal Year as contemplated by clause (i) of the proviso to Section 5.24 shall be deemed made during such preceding Fiscal Year.

 

(b) Section 1.01 of the Credit Agreement is hereby amended by inserting the following definition therein in correct alphabetical order:

 

Millennium” means Millennium Chemicals, Inc., a Delaware corporation.

 

(c) The definition of “Change of Control” in Section 1.01 of the Credit Agreement is hereby amended by deleting the second parenthetical phrase in clause (i) of such definition and by inserting the parenthetical phrase “(other than Occidental Chemical Corp. and/or its affiliates)” in place thereof.

 

(d) The definition of “Equistar” in Section 1.01 of the Credit Agreement is hereby amended by deleting the words “Millennium Chemicals Corp.” therein and inserting the word “Millennium” in place thereof.

 

(e) The definition of “Subsidiary” in Section 1.01 of the Credit Agreement is hereby amended by inserting the phrase “or any Subsidiary of a Borrower Joint Venture” at the end thereof.

 

(f) Clause (c) of Section 1.02 of the Credit Agreement is hereby amended by deleting the word “and” in the parenthetical phrase therein, inserting a comma in place thereof, and inserting the phrase “and (iii) the acquisition of Millennium” at the end of such parenthetical phrase.

 

SECTION 3. Amendments to Article 5. (a) Clause (b) of Section 5.16 of the Credit Agreement is hereby amended by adding the phrase “to the extent permitted by Section 5.24” at the end thereof.

 

(b) Clause (iv) of Section 5.19(d) of the Credit Agreement is hereby amended by inserting therein the phrase “other than any Subsidiary of Millennium” immediately following the term “JV Subsidiary”.

 

(c) Article 5 of the Credit Agreement is hereby amended by adding new Section 5.24 as follows:

 

SECTION 5.24. Investments in Borrower Joint Ventures. The Borrower will not, and will not permit any Subsidiary to, make any Investment in any Borrower Joint Venture if (i) at the time thereof or immediately after giving effect thereto, a Default would exist or (ii) if the aggregate amount of such Investments made on and after July 1, 2004 would exceed the sum of (A) $100,000,000 plus (B) the aggregate Net Cash Proceeds of Equity Issuances on or after July 1, 2004 (other than any Equity Issuance the

 

2


Net Cash Proceeds of which have been or will be used to make a prepayment of Debt pursuant to Section 5.15); provided that (i) the Borrower and its Subsidiaries may make Investments in any Borrower Joint Venture during any Fiscal Year or within 45 days after the end of such Fiscal Year in amounts that, together with all other Investments made in such Borrower Joint Venture in respect of such Fiscal Year in reliance on this proviso during such Fiscal Year or within 45 days after the end of such Fiscal Year, do not exceed the amount of dividends or distributions previously paid in respect of such Fiscal Year to the Borrower or any Subsidiary by such Borrower Joint Venture and (ii) the Borrower may issue shares of its common stock upon conversion of Millennium’s 4.000% Convertible Debentures due 2023 (and amounts of Investments permitted by this proviso shall not be taken into account for purposes of clauses (A) and (B)). For the purposes of calculations under clause (i) of the preceding proviso, Investments made within 45 days after the end of a Fiscal Year shall be deemed made during such preceding Fiscal Year.

 

SECTION 4. Representations of Borrower. The Borrower represents and warrants that (i) the representations and warranties of the Borrower set forth in Article 4 of the Credit Agreement will be true in all material respects on and as of the Amendment Effective Date (as defined below) with the same effect as though made on and as of such date, except to the extent such representations and warranties expressly relate to an earlier date and (ii) no Default will have occurred and be continuing on such date.

 

SECTION 5. Governing Law. This Amendment shall be governed by and construed in accordance with the laws of the State of New York.

 

SECTION 6. Counterparts. This Amendment may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.

 

SECTION 7. Effectiveness. This Amendment shall become effective on the first date when, and simultaneously with the time upon which, the following conditions are met (the “Amendment Effective Date”):

 

(a) the Administrative Agent shall have received counterparts hereof signed by each of the Required Lenders and the Borrower (or, in the case of any party as to which an executed counterpart shall not have been received, the Administrative Agent shall have received in form satisfactory to it facsimile or other written confirmation from such party of execution of a counterpart hereof by such party);

 

(b) the Administrative Agent and the Arrangers shall have received payment of all amendment fees, other costs, fees and expenses (including, without limitation, reasonable legal fees and expenses for which invoices shall have been submitted to the Borrower) and other compensation due and payable to any of the foregoing on or prior to the Amendment Effective Date in connection with the Loan Documents; and

 

3


(c) the Borrower’s acquisition of Millennium Chemicals, Inc. shall have been consummated.

 

Promptly after the Amendment Effective Date occurs, the Administrative Agent shall notify the Borrower, the other Agents and the Lenders thereof, and such notice shall be conclusive and binding on all parties hereto.

 

4


IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed as of the date first above written.

 

LYONDELL CHEMICAL COMPANY

By:

 

/s/ Karen A. Twitchell

   

Name: Karen A. Twitchell

   

Title: Vice President and Treasurer

 

Bank One, N.A. (Chicago Office)

By:

 

/s/ Jane Bek Keil

   

Name: Jane Bek Keil

   

Title: Director

 

Bank of America, N.A.

By:

 

/s/ Richard L. Stein

   

Name: Richard L. Stein

   

Title: Principal

 

THE BANK OF NEW YORK

By:

 

/s/ Raymond J. Palmer

   

Name: Raymond J. Palmer

   

Title: Vice President

 

5


The Bank of Nova Scotia

By:

 

/s/ Nadine Bell

   

Name: Nadine Bell

   

Title: Senior Manager

 

Citibank, N.A., Individually and as Co-

Syndication Agent

By:

 

/s/ Carolyn Sheridan

   

Name: Carolyn Sheridan

   

Title: Managing Director & Vice President

 

Crédit Industriel et Commercial

By:

 

/s/ Sean Mounier

   

Name: Sean Mounier

   

Title: First Vice President

By:

 

/s/ Marcus Edward

   

Name: Marcus Edward

   

Title: Vice President

 

Costantinus Eaton Vance CDO V, Ltd.

 

By: Eaton Vance Management, as Investment Advisor

By:

 

/s/ Payson E. Swaffield

   

Name: Payson F. Swaffield

   

Title: Vice President

 

6


Eaton Vance CDO III, Ltd.

 

By: Eaton Vance Management, as Investment Advisor

By:

 

/s/ Payson E. Swaffield

   

Name: Payson E. Swaffield

   

Title: Vice President

 

Grayson & Co

 

By: Boston Management and Research, as Investment Advisor

By:

 

/s/ Payson E. Swaffield

   

Name: Payson E. Swaffield

   

Title: Vice President

 

Senior Debt Portfolio

 

By: Boston Management and Research, as Investment Advisor

By:

 

/s/ Payson E. Swaffield

   

Name: Payson E. Swaffield

   

Title: Vice President

 

JPMorgan Chase Bank

By:

 

/s/ Stacey L. Haimes

   

Name: Stacey L. Haimes

   

Title: Vice President

 

7


Societe Generale

By:

 

/s/ Graeme Bullen

   

Name: Graeme Bullen

   

Title: Vice President

 

Galaxy CLO 1999-1, Ltd.

 

By: AIG Global Investment Corp.

As Collateral Manager

By:

 

/s/ W. Jeffrey Baxter

   

Name: W. Jeffrey Baxter

   

Title: Vice President

 

SunAmerica Life Insurance Company

 

By: AIG Global Investment Corp.

As Collateral Manager

By:

 

/s/ W. Jeffrey Baxter

   

Name: W. Jeffrey Baxter

   

Title: Vice President

 

8


UBS AG, Stamford Branch

By:

 

/s/ Saltoz Sikka

   

Name: Saltoz Sikka

   

Title: Associate Director Banking Products

Services, US

By:

 

/s/ Wilfred V. Saint

   

Name: Wilfred V. Saint

   

Title: Director Banking Products

Services, US

 

VAN KAMPEN CLO I, LIMITED

 

By: Van Kampen Investment Advisory Corp,

as Collateral Manager

By:

 

/s/ Christina Jamieson

   

Name: Christina Jamieson

   

Title: Executive Director

 

VAN KAMPEN CLO II, LIMITED

 

By: Van Kampen Investment Advisory Corp,

as Collateral Manager

By:

 

/s/ Christina Jamieson

   

Name: Christina Jamieson

   

Title: Executive Director

 

VAN KAMPEN SENIOR INCOME TRUST

 

By: Van Kampen Investment Advisory Corp.

By:

 

/s/ Christina Jamieson

   

Name: Christina Jamieson

   

Title: Executive Director

 

9


VAN KAMPEN SENIOR LOAN FUND

 

By: Van Kampen Investment Advisory Corp.

By:

 

/s/ Christina Jamieson

   

Name: Christina Jamieson

   

Title: Executive Director

 

WINDSOR LOAN FUNDING, LIMITED
By:  

/s/ Christopher A. Bondy

Name:

 

Christopher A. Bondy

Title:

 

Partner

 

Bedford CDO, Limited

By: Pacific Investment Management Company

LLC, as its Investment Advisor

By:  

/s/ Mohan V. Phansalkar

Name:

 

Mohan V. Phansalkar

Title:

 

Title: Managing Director

 

Clydesdale CLO 2001-1, Ltd.

 

By: NOMURA CORPORATE RESEARCH AND

ASSET MANAGEMENT INC., AS

COLLATERAL MANAGER

By:  

/s/ Richard W. Stewart

Name:

 

Richard W. Stewart

Title:

 

Managing Director

 

10


DELANO Company

 

By: Pacific Investment Management Company

LLC, as its Investment Advisor

By:

 

/s/ Mohan VG. Phansalkar

Name:

 

Mohan VG. Phansalkar

Title:

 

Managing Director

 

ML CLO XII PILGRIM AMERICA

 

(CAYMAN) LTD.

By: ING Investments, LLC

as its investment manager

By:

 

/s/ Charles LeMieux, OFA

Name:

 

Charles LeMieux, OFA

Title:

 

Vice President

 

ML CLO XV PILGRIM AMERICA

(CAYMAN) LTD.

By: ING Investments, LLC

as its investment manager

By:

 

/s/ Charles LeMieux, OFA

Name:

 

Charles LeMieux, OFA

Title:

 

Vice President

 

ML CLO XX PILGRIM AMERICA

(CAYMAN) LTD.

By: ING Investments, LLC

as its investment manager

By:

 

/s/ Charles LeMieux, OFA

Name:

 

Charles LeMieux, OFA

Title:

 

Vice President

 

11


ROYALTON COMPANY

By: Pacific Investment Management Company

LLC, as its Investment Advisor

By:

 

/s/ Mohan V. Phansalkar

Name:

 

Mohan V. Phansalkar

Title:

 

Managing Director

 

SunAmerica Senior Floating Rate Fund Inc.

By: Stanfield Capital Partners LLC, as

Subadvisor

By:

 

/s/ Christopher A. Bondy

Name:

 

Christopher A. Bondy

Title:

 

Partner

 

12